stockrowGlobus Medical, Inc.
GMED Healthcare Medical Devices
Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.
- Revenue
- −0.69%
- EPS
- +19.3%
- Free cash flow
- +10.1%
Quarter to September 2026, against a year earlier
Follow GMED
Alert me
Globus Medical, Inc. (GMED) Operating cash flow
Globus Medical, Inc.'s operating cash flow for fiscal 2025 was $753.4M, up 44.7% from $520.6M in fiscal 2024. Over the twelve months to 30 September 2026 it was $925.9M. Over the past ten years it has ranged from $124.0M (fiscal 2015) to $753.4M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Globus Medical, Inc. ranks 12th of 149 Medical Devices companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $753.4M | 44.72% |
| FY2024 | $520.6M | 113.82% |
| FY2023 | $243.5M | 36.44% |
| FY2022 | $178.5M | (35.40%) |
| FY2021 | $276.3M | 38.98% |
| FY2020 | $198.8M | 15.59% |
| FY2019 | $172.0M | (5.32%) |
| FY2018 | $181.6M | 14.20% |
| FY2017 | $159.1M | 7.60% |
| FY2016 | $147.8M | 19.21% |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $265.2M | 26.45% |
| Jun 2026 | $209.7M | 3.65% |
| Mar 2026 | $202.4M | (18.59%) |
| Dec 2025 | $248.6M | (0.44%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $3.1B |
| GMED Globus Medical, Inc. | $925.9M |
| PODD Insulet Corporation compare | $509.0M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| BRKR Bruker Corporation compare | $341.8M |
| PEN Penumbra, Inc. compare | $261.0M |
| TXG 10x Genomics compare | $127.1M |
| GKOS Glaukos Corporation compare | $47.7M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on GMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement